Love Pharma Inc. (LUV.CN)

0.0250 0.0000 (0.00%) As of 10:29AM EDT. Market open.

Love Pharma Inc.

355 Burrard Street
Suite 1780
Vancouver, BC V7X 1B1
Canada

https://love-pharma.com

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Zachary T. Stadnyk	Pres, CEO & Chairman	91.7k	N/A	1993
Ms. Tatiana Kovaleva	Chief Financial Officer	2k	N/A	1959
Mr. Joshua Maurice	COO & Vice-Pres of Sales	N/A	N/A	1979

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Love Pharma Inc. focuses on mental health and sexual wellness by licensing and distributing psychedelic and hemp–infused products in North America, the United Kingdom, and Europe. It offers BLOOM, a female arousal gel; and AURALIEF, a cannabis-infused sublingual strip. The company was founded in 2020 and is headquartered in Vancouver, Canada.

Corporate Governance

Love Pharma Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.